⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28891552 | 0.88 | FFAR3 (0.33) | — | |
| SCHEMBL11068655 | 0.77 | TP53 (0.32) | — | |
| SCHEMBL11460744 | 0.76 | LMNA (0.36) | — | |
| SCHEMBL3554641 | 0.75 | SMPD1 (0.40) | — | |
| SCHEMBL5566732 | 0.72 | CHRM1 (0.37) | — | |
| SCHEMBL5608521 | 0.72 | CHRM1 (0.37) | — | |
| Butyric Acid SCHEMBL4942354 | 0.71 | FFAR3 (0.45) | — | |
| SCHEMBL11425472 | 0.70 | ALDH1A1 (0.33) | — | |
| SCHEMBL22202025 | 0.70 | ALDH1A1 (0.33) | — | |
| SCHEMBL2303259 | 0.70 | ALDH1A1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9677115-B2 | Enzyme substrates for visualizing acidic organelles | MARKER GENE TECHNOLOGIES, INC. (US) | 2017-06-13 | — | — | US | disclosed |
| US-20130252268-A1 | Enzyme substrates for visualizing acidic organelles | MARKER GENE TECHNOLOGIES, INC. (US) | 2013-09-26 | — | — | US | disclosed |
| US-8460862-B2 | Enzyme substrates for visualizing acidic organelles | Marker Gene Technologies (US) | 2013-06-11 | — | — | US | disclosed |
| US-20100233744-A1 | Enzyme substrates for visualizing acidic organelles | MARKER GENE TECHNOLOGIES, INC. | 2010-09-16 | — | — | US | disclosed |
| EP-1149109-B1 | METHOD FOR DEPROTECTING OLIGONUCLEOTIDES | GE HEALTHCARE BIO SCIENCES (US) | 2009-09-16 | — | — | EP | disclosed |
| US-6887990-B1 | Method for deprotecting oligonucleotides | AMERSHAM BIOSCIENCES CORP (US) | 2005-05-03 | — | — | US | disclosed |
| WO-2002051958-A1 | ELECTROACTIVE POLYARYLAMINE-TYPE COMPOSITIONS | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2002-07-04 | — | — | WO | disclosed |
| EP-1149109-A1 | METHOD FOR DEPROTECTING OLIGONUCLEOTIDES | Amersham Pharmacia Biotech Inc (US) | 2001-10-31 | — | — | EP | disclosed |
| WO-2000046231-A1 | METHOD FOR DEPROTECTING OLIGONUCLEOTIDES | AMERSHAM PHARMACIA BIOTECH INC. (US) | 2000-08-10 | — | — | WO | disclosed |
| EP-0391594-B1 | Cloning genes from streptomyces avermitilis for avermectin biosynthesis and the methods for their use | MERCK & CO INC (US) | 1995-10-18 | — | — | EP | disclosed |
| US-5252474-A | Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use | MERCK & CO., INC. (US) | 1993-10-12 | — | — | US | disclosed |
| EP-0391594-A2 | Cloning genes from streptomyces avermitilis for avermectin biosynthesis and the methods for their use | MERCK & CO. INC. (US) | 1990-10-10 | — | — | EP | disclosed |
| EP-0223974-A1 | N-Substituted-N-[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)-phenyl]alkanamides, carbamates and ureas | AMERICAN CYANAMID COMPANY (US) | 1987-06-03 | — | — | EP | disclosed |